FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099852272> ?p ?o ?g. }

• W2099852272 endingPage "157" @default.
• W2099852272 startingPage "150" @default.
• W2099852272 abstract "The aim of the study was 1) to establish the prevalence of GAD antibodies (GADab) in a population-based study of type 2 diabetes in western Finland, 2) to genetically and phenotypically characterize this subgroup, and 3) to provide a definition for latent autoimmune diabetes in adults (LADA). The prevalence of GADab was 9.3% among 1,122 type 2 diabetic patients, 3.6% among 558 impaired glucose tolerance (IGT) subjects, and 4.4% among 383 nondiabetic control subjects. Islet antigen 2 antibodies (IA2ab) or islet cell antibodies were detected in only 0.5% of the GADab- patients. The GADab+ patients had lower fasting C-peptide concentrations (median [interquartile range]: 0.46 [0.45] vs. 0.62 [0.44] nmol/l, P = 0.0002) and lower insulin response to oral glucose compared with GADab- patients. With respect to features of the metabolic syndrome, the GADab+ patients had lower systolic (140 [29.1] vs. 148 [26.0] mmHg, P = 0.009) and diastolic (79.2 [17.6] vs. 81.0 [13.1] mmHg, P = 0.030) blood pressure values, as well as lower triglyceride concentrations (1.40 [1.18] vs. 1.75 [1.25] mmol/l, P = 0.003). GADab+ men had a lower waist-to-hip ratio compared with GADab- patients. Compared with GADab- patients and control subjects, the GADab+ patients had an increased frequency HLA-DQB1*0201/0302 (13 vs. 4%; P = 0.002) and other genotypes containing the *0302 allele (22 vs. 12%; P = 0.010). However, the frequency of these high-risk genotypes was significantly lower in GADab+ type 2 patients than in type 1 diabetes of young or adult onset (0201/0302 or 0302/X: 36 vs. 66 vs. 64%, P &lt; 0.001). The GADab+ type 2 group did not differ from control subjects with respect to genotypes containing the protective DQB1-alleles *0602 or *0603, nor with respect to the type 1 high-risk genotype in the IDDM1 (Hph1 +/+). We conclude that GADab+ patients differ from both GADab- type 2 diabetic patients and type 1 diabetic patients with respect to beta-cell function, features of the metabolic syndrome, and type 1 diabetes susceptibility genes. Further, we propose that LADA be defined as GADab positivity (&gt;5 relative units) in patients older than 35 years at onset of type 2 diabetes." @default.
• W2099852272 created "2016-06-24" @default.
• W2099852272 creator A5005130084 @default.
• W2099852272 creator A5006303667 @default.
• W2099852272 creator A5014032932 @default.
• W2099852272 creator A5020289582 @default.
• W2099852272 creator A5022014605 @default.
• W2099852272 creator A5023546213 @default.
• W2099852272 creator A5040385742 @default.
• W2099852272 creator A5045723915 @default.
• W2099852272 creator A5057557099 @default.
• W2099852272 creator A5061973111 @default.
• W2099852272 creator A5068302783 @default.
• W2099852272 creator A5071201172 @default.
• W2099852272 creator A5074771810 @default.
• W2099852272 creator A5079322104 @default.
• W2099852272 creator A5085907181 @default.
• W2099852272 date "1999-01-01" @default.
• W2099852272 modified "2023-10-11" @default.
• W2099852272 title "Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies." @default.
• W2099852272 cites W1968617596 @default.
• W2099852272 cites W1972182005 @default.
• W2099852272 cites W1979347124 @default.
• W2099852272 cites W1982136783 @default.
• W2099852272 cites W2005865410 @default.
• W2099852272 cites W2027412364 @default.
• W2099852272 cites W2032402557 @default.
• W2099852272 cites W2034957838 @default.
• W2099852272 cites W2046548199 @default.
• W2099852272 cites W2046806236 @default.
• W2099852272 cites W2074251983 @default.
• W2099852272 cites W2122298518 @default.
• W2099852272 cites W2127591233 @default.
• W2099852272 cites W2137638424 @default.
• W2099852272 cites W2148117345 @default.
• W2099852272 cites W2151688741 @default.
• W2099852272 cites W2156555887 @default.
• W2099852272 cites W2342004103 @default.
• W2099852272 cites W2616856494 @default.
• W2099852272 doi "https://doi.org/10.2337/diabetes.48.1.150" @default.
• W2099852272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9892237" @default.
• W2099852272 hasPublicationYear "1999" @default.
• W2099852272 type Work @default.
• W2099852272 sameAs 2099852272 @default.
• W2099852272 citedByCount "460" @default.
• W2099852272 countsByYear W20998522722012 @default.
• W2099852272 countsByYear W20998522722013 @default.
• W2099852272 countsByYear W20998522722014 @default.
• W2099852272 countsByYear W20998522722015 @default.
• W2099852272 countsByYear W20998522722016 @default.
• W2099852272 countsByYear W20998522722017 @default.
• W2099852272 countsByYear W20998522722018 @default.
• W2099852272 countsByYear W20998522722019 @default.
• W2099852272 countsByYear W20998522722020 @default.
• W2099852272 countsByYear W20998522722021 @default.
• W2099852272 countsByYear W20998522722022 @default.
• W2099852272 countsByYear W20998522722023 @default.
• W2099852272 crossrefType "journal-article" @default.
• W2099852272 hasAuthorship W2099852272A5005130084 @default.
• W2099852272 hasAuthorship W2099852272A5006303667 @default.
• W2099852272 hasAuthorship W2099852272A5014032932 @default.
• W2099852272 hasAuthorship W2099852272A5020289582 @default.
• W2099852272 hasAuthorship W2099852272A5022014605 @default.
• W2099852272 hasAuthorship W2099852272A5023546213 @default.
• W2099852272 hasAuthorship W2099852272A5040385742 @default.
• W2099852272 hasAuthorship W2099852272A5045723915 @default.
• W2099852272 hasAuthorship W2099852272A5057557099 @default.
• W2099852272 hasAuthorship W2099852272A5061973111 @default.
• W2099852272 hasAuthorship W2099852272A5068302783 @default.
• W2099852272 hasAuthorship W2099852272A5071201172 @default.
• W2099852272 hasAuthorship W2099852272A5074771810 @default.
• W2099852272 hasAuthorship W2099852272A5079322104 @default.
• W2099852272 hasAuthorship W2099852272A5085907181 @default.
• W2099852272 hasConcept C119060515 @default.
• W2099852272 hasConcept C126322002 @default.
• W2099852272 hasConcept C134018914 @default.
• W2099852272 hasConcept C159654299 @default.
• W2099852272 hasConcept C203014093 @default.
• W2099852272 hasConcept C2777180221 @default.
• W2099852272 hasConcept C2778163477 @default.
• W2099852272 hasConcept C2778913445 @default.
• W2099852272 hasConcept C2781232474 @default.
• W2099852272 hasConcept C2908647359 @default.
• W2099852272 hasConcept C555293320 @default.
• W2099852272 hasConcept C71924100 @default.
• W2099852272 hasConcept C99454951 @default.
• W2099852272 hasConceptScore W2099852272C119060515 @default.
• W2099852272 hasConceptScore W2099852272C126322002 @default.
• W2099852272 hasConceptScore W2099852272C134018914 @default.
• W2099852272 hasConceptScore W2099852272C159654299 @default.
• W2099852272 hasConceptScore W2099852272C203014093 @default.
• W2099852272 hasConceptScore W2099852272C2777180221 @default.
• W2099852272 hasConceptScore W2099852272C2778163477 @default.
• W2099852272 hasConceptScore W2099852272C2778913445 @default.
• W2099852272 hasConceptScore W2099852272C2781232474 @default.
• W2099852272 hasConceptScore W2099852272C2908647359 @default.
• W2099852272 hasConceptScore W2099852272C555293320 @default.
• W2099852272 hasConceptScore W2099852272C71924100 @default.

• next